Get the app
US › Healthcare

Clearpoint Neuro Inc (CLPT)

US · Healthcare · Medical Devices

$9.07-5.91%
Last close · 2026-10-16

Latest quarter · ended 2026-06-30

Revenue
$10.9M
Revenue YoY
+18.1%
Net profit
$-11.3M
EPS
$-0.38
EPS estimate
$-0.29
Net margin
-104.2%

EPS came in at -0.38 against a street estimate of -0.29 — a miss of 31.0%.

Key statistics

Market cap
$319.7M
Forward P/E
12.1
P/B
42.43
Book value
$0.35
EPS (TTM)
$-1.18
52-week high
$28.10
52-week low
$8.27
50-day MA
$14.03
200-day MA
$13.33
Beta
1.29

Analyst view

Analysts rate Clearpoint Neuro Inc a strong buy (2 buy, 0 hold, 0 sell out of 2) with an average price target of $23.50.

Shareholding

Insiders
5.48%
Institutions
52.48%

Largest institutional holders

FundStake
BlackRock Inc7.80%
Mak Capital One LLC7.79%
Vanguard Capital Management, LLC4.04%
State Street Corp2.68%
Geode Capital Management, LLC2.46%
Lane Generational LLC1.46%
UBS Group AG1.41%
Millennium Management LLC1.17%

See the full picture

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Clearpoint Neuro Inc — free to start.

Open in the appGoogle PlayApp Store

Other Healthcare companies

Eli Lilly and CompanyJohnson & JohnsonAbbVie IncUnitedHealth Group IncorporatedMerck & Company IncNovartis AG ADRAstraZeneca PLCThermo Fisher Scientific IncAmgen IncGilead Sciences IncAbbott LaboratoriesNovo Nordisk A/S

Data updated 2026-10-19.